Skip to content

SEARCH

Investing News
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

Search

SEARCH FOR AN ARTICLE

Search

Investing News
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

HomeNUMI-PR-25

NUMI-PR-25

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology

July 30, 2021

LATEST NEWS

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from Stock Street News.

I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

Market Jar Media Inc. © 2024